NASDAQ: ATOMAtomera Inc Stock
$5.64-0.40 (-6.62%)
Updated Apr 17, 2024
ATOM Price
$5.64
Fair Value Price
-$0.17
Market Cap
$150.14M
52 Week Low
$4.96
52 Week High
$10.72
P/E
-7.05x
P/B
8.26x
P/S
315.51x
PEG
N/A
Dividend Yield
N/A
Revenue
$550.00k
Earnings
-$19.79M
Gross Margin
94.9%
Operating Margin
-3,562.91%
Profit Margin
-3,598.2%
Debt to Equity
0.32
Operating Cash Flow
-$15M
Beta
1.7
Next Earnings
Apr 25, 2024
Ex-Dividend
N/A
Next Dividend
N/A
ATOM Overview
Atomera Incorporated develops, commercializes, and licenses proprietary materials, processes, and technologies for the semiconductor industry in North America and the Asia Pacific. The company's lead technology is the Mears Silicon Technology, a thin film of reengineered silicon that can be applied as a transistor channel enhancement to CMOS-type transistors. Its customers include foundries, integrated device manufacturers, fabless semiconductor manufacturers, original equipment manufacturers, and electronic design automation companies. The company was formerly known as Mears Technologies, Inc. and changed its name to Atomera Incorporated in January 2016. Atomera Incorporated was incorporated in 2001 and is headquartered in Los Gatos, California.
Zen Score
–
Industry Average (38)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ATOM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ATOM ($5.64) is overvalued by 3,368.24% relative to our estimate of its Fair Value price of -$0.17 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ATOM ($5.64) is not significantly undervalued (3,368.24%) relative to our estimate of its Fair Value price of -$0.17 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ATOM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ATOM due diligence checks available for Premium users.
Be the first to know about important ATOM news, forecast changes, insider trades & much more!
ATOM News
Valuation
ATOM fair value
Fair Value of ATOM stock based on Discounted Cash Flow (DCF)
Price
$5.64
Fair Value
-$0.17
Undervalued by
3,368.24%
ATOM ($5.64) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ATOM ($5.64) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ATOM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ATOM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-7.05x
Industry
38.69x
Market
41.64x
ATOM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
8.26x
Industry
11.36x
ATOM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ATOM's financial health
Profit margin
Revenue
$550.0k
Net Income
-$4.6M
Profit Margin
-832.7%
ATOM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ATOM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$24.0M
Liabilities
$5.9M
Debt to equity
0.32
ATOM's short-term assets ($20.40M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ATOM's short-term assets ($20.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ATOM's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ATOM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.9M
Investing
$875.0k
Financing
$2.0M
ATOM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ATOM vs Semiconductor Equipment Stocks
Atomera Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.